FDA User Fees On Sequester Chopping Block: A Deeper Wound That Might Heal Quicker
This article was originally published in The Pink Sheet Daily
Executive Summary
White House Office of Management and Budget list shows nearly all fees will be subject to the budget cuts scheduled to go into effect Jan. 2 absent congressional action.
You may also be interested in...
How Do You Solve A Problem Like Sequestration?
FDA and advocates wait for OMB to clarify how the estimated 7.8% budget cut should be implemented, if it is enacted. Former agency officials say it could lead to hiring freezes and program delays.
FDASIA Study Mandates Focus On Performance, But Could Slow Reviews
Advocates for the agency worry that while each of the performance assessments seems reasonable individually, together the reports could burden staff to the point of pulling some from application reviews or other tasks to help complete them.
FDA's Projected $20 Mil. In 2013 Biosimilar User Fees Translates Into 68 More Staffers
Administration’s proposed fiscal year 2013 spending plan includes $4.5 billion for FDA, with $2 billion or 44% provided by various user fees.